| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1083523788 |
| P356 | DOI | 10.1186/S12936-017-1712-4 |
| P932 | PMC publication ID | 5290657 |
| P698 | PubMed publication ID | 28153004 |
| P50 | author | Eric S Halsey | Q115615630 |
| Eldin Talundzic | Q115615634 | ||
| Pedro Rafael Dimbu | Q115615637 | ||
| Filomeno Fortes | Q115615640 | ||
| Pascal Ringwald | Q30103027 | ||
| Venkatachalam Udhayakumar | Q60032286 | ||
| Mateusz M Plucinski | Q87820118 | ||
| P2093 | author name string | Carolina Miguel Ferreira | |
| Claudete Samutondo | |||
| Eliane Mbounga | |||
| Joltim Quivinja | |||
| Yun He | |||
| Denise O Garrett | |||
| Dhruviben S Patel | |||
| Richard Kiniffo | |||
| Aleixo Panzo Macaia | |||
| Julia S Kelley | |||
| Marília Afonso | |||
| P2860 | cites work | Artemisinin Resistance in Plasmodium falciparum Malaria | Q22061852 |
| A molecular marker of artemisinin-resistant Plasmodium falciparum malaria | Q22061872 | ||
| Artemisinin-based combination therapy for treating uncomplicated malaria | Q24241785 | ||
| The effect of dosing regimens on the antimalarial efficacy of dihydroartemisinin-piperaquine: a pooled analysis of individual patient data | Q26822489 | ||
| Polymorphisms in K13 and Falcipain-2 Associated with Artemisinin Resistance Are Not Prevalent in Plasmodium falciparum Isolated from Ugandan Children | Q27861962 | ||
| Plasmodium falciparum drug resistance in Angola | Q28075079 | ||
| Absence of putative artemisinin resistance mutations among Plasmodium falciparum in Sub-Saharan Africa: a molecular epidemiologic study | Q30389796 | ||
| Epidemiology of drug-resistant malaria | Q30830669 | ||
| The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data | Q30936416 | ||
| Safety and efficacy of dihydroartemisinin-piperaquine in falciparum malaria: a prospective multi-centre individual patient data analysis | Q33489551 | ||
| Severe malaria not responsive to artemisinin derivatives in man returning from Angola to Vietnam | Q33816332 | ||
| Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria | Q33978975 | ||
| Tracking Origins and Spread of Sulfadoxine-Resistant Plasmodium falciparum dhps Alleles in Thailand | Q34483523 | ||
| Contrasting benefits of different artemisinin combination therapies as first-line malaria treatments using model-based cost-effectiveness analysis | Q34677891 | ||
| Selective sweeps and genetic lineages of plasmodium falciparum drug -resistant alleles in Ghana | Q34763548 | ||
| Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for treatment of uncomplicated malaria in children in Zaire and Uíge Provinces, angola | Q34922694 | ||
| The effect of dose on the antimalarial efficacy of artemether-lumefantrine: A systematic review and pooled analysis of individual patient data | Q35580908 | ||
| Genetic Analysis and Species Specific Amplification of the Artemisinin Resistance-Associated Kelch Propeller Domain in P. falciparum and P. vivax | Q35751430 | ||
| Robust Algorithm for Systematic Classification of Malaria Late Treatment Failures as Recrudescence or Reinfection Using Microsatellite Genotyping | Q36075776 | ||
| Evaluation of artemether-lumefantrine efficacy in the treatment of uncomplicated malaria and its association with pfmdr1, pfatpase6 and K13-propeller polymorphisms in Luanda, Angola | Q36376796 | ||
| Plasmodium falciparum drug resistance phenotype as assessed by patient antimalarial drug levels and its association with pfmdr1 polymorphisms | Q36584636 | ||
| Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study | Q36689509 | ||
| Temporal trends of molecular markers associated with artemether-lumefantrine tolerance/resistance in Bagamoyo district, Tanzania | Q37066203 | ||
| The role of pfmdr1 in Plasmodium falciparum tolerance to artemether-lumefantrine in Africa | Q43945706 | ||
| Severe Malaria Not Responsive to Artemisinin Derivatives in Man Returning from Angola to Vietnam. | Q53797209 | ||
| Severe Malaria Not Responsive to Artemisinin Derivatives in Man Returning from Angola to Vietnam. | Q55442500 | ||
| P433 | issue | 1 | |
| P921 | main subject | Angola | Q916 |
| malaria | Q12156 | ||
| artesunate | Q707939 | ||
| lumefantrine | Q904464 | ||
| amodiaquine | Q239569 | ||
| Plasmodium falciparum | Q311383 | ||
| Plasmodium falciparum malaria | Q18554672 | ||
| P304 | page(s) | 62 | |
| P577 | publication date | 2017-02-02 | |
| P1433 | published in | Malaria Journal | Q15749954 |
| P1476 | title | Efficacy of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, 2015. | |
| P478 | volume | 16 |
| Q92608192 | A Computer Modelling Approach To Evaluate the Accuracy of Microsatellite Markers for Classification of Recurrent Infections during Routine Monitoring of Antimalarial Drug Efficacy |
| Q57789692 | Absence of a High Level of Duplication of the Plasmepsin II Gene in Africa |
| Q92787223 | Absence of kelch13 artemisinin resistance markers but strong selection for lumefantrine-tolerance molecular markers following 18 years of artemisinin-based combination therapy use in Mpumalanga Province, South Africa (2001-2018) |
| Q47998548 | Antimalarial Resistance Unlikely To Explain U.K. Artemether-Lumefantrine Failures |
| Q92375746 | Antimalarial drug resistance in Africa: the calm before the storm? |
| Q92827127 | Are k13 and plasmepsin II genes, involved in Plasmodium falciparum resistance to artemisinin derivatives and piperaquine in Southeast Asia, reliable to monitor resistance surveillance in Africa? |
| Q92639063 | Clearance dynamics of lactate dehydrogenase and aldolase following antimalarial treatment for Plasmodium falciparum infection |
| Q52609473 | Efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017. |
| Q56376468 | Efficacy of artemisinin-based combination therapies and prevalence of molecular markers associated with artemisinin, piperaquine and sulfadoxine-pyrimethamine resistance in Sierra Leone |
| Q64124367 | Evolution and genetic diversity of the gene associated with artemisinin delayed parasite clearance in |
| Q56363463 | High efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Muheza and Kigoma Districts, Tanzania |
| Q48023089 | Impacts of Antimalarial Drugs on Plasmodium falciparum Drug Resistance Markers, Western Kenya, 2003-2015. |
| Q45199456 | Interpreting Data from Passive Surveillance of Antimalarial Treatment Failures |
| Q92909416 | Low polymorphisms in pfact, pfugt and pfcarl genes in African Plasmodium falciparum isolates and absence of association with susceptibility to common anti-malarial drugs |
| Q92016827 | Monitoring of efficacy, tolerability and safety of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Lambaréné, Gabon: an open-label clinical trial |
| Q49843529 | Prevalence of molecular markers of artemisinin and lumefantrine resistance among patients with uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2015. |
| Q52615236 | Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial. |
| Q52653027 | Rapamycin promotes the anticancer action of dihydroartemisinin in breast cancer MDA-MB-231 cells by regulating expression of Atg7 and DAPK. |
| Q64232067 | Resistance to Artemisinin Combination Therapies (ACTs): Do Not Forget the Partner Drug! |
| Q92993514 | Safety and tolerability of single low-dose primaquine in a low-intensity transmission area in South Africa: an open-label, randomized controlled trial |
| Q101127653 | Spatial and molecular mapping of Pfkelch13 gene polymorphism in Africa in the era of emerging Plasmodium falciparum resistance to artemisinin: a systematic review |
| Q39206934 | pfmdr1 (Plasmodium falciparum multidrug drug resistance gene 1): a pivotal factor in malaria resistance to artemisinin combination therapies |